6505-- Nuclear Medicine Radiopharmaceuticals
ID: 36C25225Q0325Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF252-NETWORK CONTRACT OFFICE 12 (36C252)MILWAUKEE, WI, 53214, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e186a3b8d58f426f9af04b8298626b5b/view
Timeline
    Description

    The Department of Veterans Affairs is issuing a Request for Quotations (RFQ) for the procurement of nuclear medicine radiopharmaceuticals required at the Captain James A. Lovell Federal Health Care Center in North Chicago, IL. The contract will cover the supply of various specified radiopharmaceuticals over a base year from April 1, 2025, to March 31, 2026, with options for four additional years, emphasizing compliance with regulatory standards and quality control measures. These radiopharmaceuticals are critical for diagnostic testing and quality assurance in medical settings, ensuring accurate and safe patient care. Interested suppliers must submit their responses by March 12, 2025, at 12:00 p.m. CST, and can direct inquiries to the contracting officer, Tiffany Pevey, via email at Tiffany.Pevey@va.gov.

    Point(s) of Contact
    Tiffany PeveyContracting Officer
    Email Only
    Tiffany.Pevey@va.gov
    Files
    Title
    Posted
    36C25225Q0325_1.docx
    The Department of Veterans Affairs is issuing a Request for Quotations (RFQ) for radiopharmaceuticals required at the Captain James A. Lovell FHCC in North Chicago, IL, for diagnostic testing and quality assurance. The solicitation number is 36C25225Q0325, with responses due by March 12, 2025, at 12:00 p.m. CST. The RFQ is unrestricted, with a NAICS code of 325412 for Pharmaceutical Preparation Manufacturing. Suppliers must provide various specified radiopharmaceuticals over a base year from April 1, 2025, to March 31, 2026, with options for four additional years. Offerors must comply with extensive regulatory standards, including licensing by the Nuclear Regulatory Commission and adherence to quality control measures. Deliveries should occur during specified weekday hours, with an emphasis on the importance of label accuracy and safety adherence. Selection will be based on a comparative evaluation of quotes prioritizing cost-effectiveness and compliance with the solicitation terms. Responses must include a statement of acceptance of terms, and late submissions will be subject to established penalties. Questions regarding the solicitation should be directed to the contracting officer, Tiffany Pevey.
    Lifecycle
    Title
    Type
    6505-- Nuclear Medicine Radiopharmaceuticals
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the procurement of radiopharmaceuticals to support cancer treatment at the Naval Medical Center Portsmouth. The contract aims to secure a supply of various medical imaging agents, including Tc-99m isotopes, I-123, and F-18 compounds, essential for diagnostic imaging and therapeutic applications, over a five-year period from April 1, 2025, to March 31, 2030, with options for renewal. This procurement is critical for ensuring the availability of necessary medical supplies within the military healthcare system, emphasizing compliance with safety regulations and cost-effectiveness. Interested vendors, particularly small businesses, are encouraged to submit proposals by March 11, 2025, and can contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or 210-952-8111 for further information.
    6505-- Intent to Sole Source Xofigo - Radiopharmaceutical for Lebanon VAMC
    Buyer not available
    The Department of Veterans Affairs intends to sole source a contract for the procurement of Xofigo (Radium 223 dichloride) for the Lebanon VA Medical Center. This procurement aims to fulfill the medical center's nuclear medicine requirements, ensuring the delivery, storage, and quality management of this critical radioisotope used in cancer treatment for patients with resistant prostate cancer. The contract is set for a duration of one year, beginning June 29, 2025, with interested vendors required to submit a one-page capability statement by March 13, 2025, at 10:00 AM EST. For further inquiries, vendors can contact Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    6515--FVA Hot Lab Equipment
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hot Lab Equipment for the Nuclear Medicine Department at the Fredericksburg Health Care Center in Virginia. This Request for Proposal (RFP) is specifically set aside for small businesses, requiring contractors to be verified as such at the time of quote submission and award. The procurement includes essential items such as dose calibrators and lead-lined cabinets, with detailed specifications and delivery requirements outlined, emphasizing the importance of minimal disruption to ongoing operations during installation. Interested vendors should contact Contract Specialist Stephen M. Nassan at Stephen.Nassan@va.gov for further details, as adherence to contract clauses and regulations is mandatory throughout the process.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    36C77025Q0138_3 Pharm CLINs Charleston CMOP
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for pharmaceutical supplies under requisition number 36C77025Q0138, specifically for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The procurement includes a variety of pharmaceutical products, with requirements for compliance with federal regulations, including packaging and barcoding standards, and mandates that all supplies must have expiration dates exceeding one year from the delivery date. This initiative is crucial for ensuring that the Department can continue to provide quality healthcare services to veterans. Interested vendors must submit their quotes, including necessary documentation, by March 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Lacie A Nowak at lacie.nowak@va.gov.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.